<scp>HPV E6</scp>/<scp>E7 mRNA</scp> screening alone can be used as a screening method for cervical cancer in premenopausal women in China: A retrospective study
The present study suggests that initial screening with HPV E6/E7 mRNA testing rather than combined screening is a suitable candidate for cervical cancer screening in China (especially for premenopausal women) based on economic reasons.
Authors
- Shirong Yang (ORCID: https://orcid.org/0009-0008-3225-9718)
- Yingying Gong (ORCID: https://orcid.org/0000-0001-7965-2236)
- Beibei Du
- Linqing Yang
- Yingying Ma (ORCID: https://orcid.org/0000-0002-6245-2200)
- Yunfei Wang (ORCID: https://orcid.org/0009-0006-6530-3119)
- Ying Liu (ORCID: https://orcid.org/0000-0002-7164-962X)
Institutions
- Peking University Shenzhen Hospital (CN)
- Affiliated Hospital of Jining Medical University (CN)
Publication Details
- Journal
- International Journal of Gynecology & Obstetrics
- Published
- 2024-11-25
- DOI
- https://doi.org/10.1002/ijgo.16043
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Jining Medical University